Financhill
Sell
14

NOTR Quote, Financials, Valuation and Earnings

Last price:
$13.00
Seasonality move :
20.83%
Day range:
$13.00 - $13.00
52-week range:
$13.00 - $13.00
Dividend yield:
0%
P/E ratio:
7,107.71x
P/S ratio:
350.40x
P/B ratio:
1,477.98x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$547.3M
Revenue:
$597.6K
EPS (TTM):
$0.00
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue -- -- -- $69.3K $597.6K
Revenue Growth (YoY) -- -- -- -- 761.8%
 
Cost of Revenues -- -- -- $9.7K $113.2K
Gross Profit -- -- -- $59.6K $484.4K
Gross Profit Margin -- -- -- 86.01% 81.06%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $230.1K $735.9K
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $230.1K $735.9K
Operating Income -- -- -- -$170.5K -$251.5K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$170.5K -$251.5K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$170.5K -$251.5K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$170.5K -$251.5K
 
Basic EPS (Cont. Ops) -- -- -- -$0.04 -$0.01
Diluted EPS (Cont. Ops) -- -- -- -$0.04 -$0.01
Weighted Average Basic Share -- -- -- $4.7M $33.8M
Weighted Average Diluted Share -- -- -- $4.7M $33.8M
 
EBITDA -- -- -- -$170.5K -$251.5K
EBIT -- -- -- -$170.5K -$251.5K
 
Revenue (Reported) -- -- -- $69.3K $597.6K
Operating Income (Reported) -- -- -- -$170.5K -$251.5K
Operating Income (Adjusted) -- -- -- -$170.5K -$251.5K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $192.2K $573K
Revenue Growth (YoY) -- -- -- -- 198.17%
 
Cost of Revenues -- -- -- $31.8K $148.2K
Gross Profit -- -- -- $160.3K $424.7K
Gross Profit Margin -- -- -- 83.44% 74.13%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $217.5K $368.5K
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $217.5K $368.5K
Operating Income -- -- -- -$57.2K $56.2K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$57.2K $56.2K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$57.2K $56.2K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$57.2K $56.2K
 
Basic EPS (Cont. Ops) -- -- -- -$0.00 $0.00
Diluted EPS (Cont. Ops) -- -- -- -$0.00 $0.00
Weighted Average Basic Share -- -- -- $40.4M $42.1M
Weighted Average Diluted Share -- -- -- $40.4M $42.1M
 
EBITDA -- -- -- -$57.2K $56.2K
EBIT -- -- -- -$57.2K $56.2K
 
Revenue (Reported) -- -- -- $192.2K $573K
Operating Income (Reported) -- -- -- -$57.2K $56.2K
Operating Income (Adjusted) -- -- -- -$57.2K $56.2K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- -- $1.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $332K
Gross Profit -- -- -- -- $1.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $481K $1.2M
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- $481K $1.2M
Operating Income -- -- -- -$233.1K $38.7K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -$233.1K $38.7K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -$233.1K $38.7K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -$233.1K $38.7K
 
Basic EPS (Cont. Ops) -- -- -- -$0.02 $0.00
Diluted EPS (Cont. Ops) -- -- -- -$0.02 $0.00
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -$233.1K $38.7K
EBIT -- -- -- -$233.1K $38.7K
 
Revenue (Reported) -- -- -- -- $1.5M
Operating Income (Reported) -- -- -- -$233.1K $38.7K
Operating Income (Adjusted) -- -- -- -$233.1K $38.7K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue -- -- -- $294K $1.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $46.1K $264.9K
Gross Profit -- -- -- $247.9K $969.9K
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $7.7K $20K $77.8K $481K $892.8K
Other Inc / (Exp) -- -- $8.7K $30 --
Operating Expenses $7.7K $20K $77.8K $481K $892.8K
Operating Income -$7.7K -$20K -$77.8K -$233.1K $77K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$7.7K -$20K -$69.1K -$233.1K $77K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$7.7K -$20K -$69.1K -$233.1K $77K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$7.7K -$20K -$69.1K -$233.1K $77K
 
Basic EPS (Cont. Ops) -$0.00 -$0.00 -$0.01 -$0.02 $0.00
Diluted EPS (Cont. Ops) -$0.00 -$0.00 -$0.01 -$0.02 $0.00
Weighted Average Basic Share $16.4M $16.4M $16.4M $99.5M $125.1M
Weighted Average Diluted Share $16.4M $16.4M $16.4M $99.5M $125.1M
 
EBITDA -$7.7K -$20K -$77.8K -$233.1K $77K
EBIT -$7.7K -$20K -$77.8K -$233.1K $77K
 
Revenue (Reported) -- -- -- $294K $1.2M
Operating Income (Reported) -$7.7K -$20K -$77.8K -$233.1K $77K
Operating Income (Adjusted) -$7.7K -$20K -$77.8K -$233.1K $77K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents -- -- -- $11.6K $19.2K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $7.8K $36.5K
Inventory -- -- -- $12.3K $37.7K
Prepaid Expenses -- -- -- -- --
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $31.6K $93.4K
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $31.6K $93.4K
 
Accounts Payable -- -- -- $3.4K $7.7K
Accrued Expenses -- -- -- -- $1.5K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $48.8K $100.2K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $48.8K $100.2K
 
Common Stock -- -- -- $560 $4.1K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -$17.2K -$6.8K
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- -$17.2K -$6.8K
 
Total Liabilities and Equity -- -- -- $31.6K $93.4K
Cash and Short Terms -- -- -- $11.6K $19.2K
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents -- -- -- $42K $333.2K
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- $18.7K $31.9K
Inventory -- -- -- $34.3K $42.2K
Prepaid Expenses -- -- -- -- $1.4K
Other Current Assets -- -- -- -- --
Total Current Assets -- -- -- $95K $415.8K
 
Property Plant And Equipment -- -- -- -- --
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- --
Total Assets -- -- -- $95K $415.8K
 
Accounts Payable -- -- -- $8K $8.5K
Accrued Expenses -- -- -- -- $2.5K
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities -- -- -- $86.4K $45.6K
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- $86.4K $45.6K
 
Common Stock -- -- -- $4.1K $4.2K
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity -- -- -- $8.6K $370.3K
 
Total Liabilities and Equity -- -- -- $95K $415.8K
Cash and Short Terms -- -- -- $42K $333.2K
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -- -- -- -$170.5K -$251.5K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$7.8K -$28.7K
Change in Inventories -- -- -- -$12.3K -$25.4K
Cash From Operations -- -- -- -$182.8K -$307.8K
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $44.3K $41.7K
Cash From Financing -- -- -- $194.3K $315.5K
 
Beginning Cash (CF) -- -- -- $100 $11.6K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $11.5K $7.7K
Ending Cash (CF) -- -- -- $11.6K $19.2K
 
Levered Free Cash Flow -- -- -- -$182.8K -$307.8K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$57.2K $56.2K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$2.9K -$4.3K
Change in Inventories -- -- -- -$18.5K -$1.6K
Cash From Operations -- -- -- -$70.4K $52.2K
 
Capital Expenditures -- -- -- -- $7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $193.3K $319.1K
Cash From Financing -- -- -- $82.1K $144.1K
 
Beginning Cash (CF) -- -- -- $30.3K $143.9K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $11.7K $189.3K
Ending Cash (CF) -- -- -- $42K $333.2K
 
Levered Free Cash Flow -- -- -- -$70.4K $45.2K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -- -- -- -$233.1K $38.7K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- -$13.2K
Change in Inventories -- -- -- -- -$7.9K
Cash From Operations -- -- -- -$270.9K $17K
 
Capital Expenditures -- -- -- -- $7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- $16.2K
Cash From Financing -- -- -- $281.8K $281.2K
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $10.9K $291.2K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -$270.9K $17K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$7.7K -$20K -$69.1K -$233.1K $77K
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$11K $4.5K
Change in Inventories -- -- -- -$22K -$4.5K
Cash From Operations -$1.6K -$28.9K -$79.9K -$270.9K $73.5K
 
Capital Expenditures -- -- -- -- $7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$7K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -$5.4K $8.3K -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $930 -- -- $273K $247.5K
Cash From Financing $22.2K $10.9K -- $281.8K $247.5K
 
Beginning Cash (CF) $25.5K $22.8K $191.7K $79.7K $256.1K
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $20.6K -$18K -$79.9K $10.9K $314K
Ending Cash (CF) $46.1K $4.8K $111.8K $90.6K $570.1K
 
Levered Free Cash Flow -$1.6K -$28.9K -$79.9K -$271K $66.5K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock